Antagonistic role of IL-1ß and NLRP3/IL-18 genetics in chronic HIV-1 infection

Copyright © 2019 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 209(2019) vom: 16. Dez., Seite 108266
1. Verfasser: Reis, Edione C (VerfasserIn)
Weitere Verfasser: Leal, Vinicius N C, da Silva, Lais T, Dos Reis, Marilia M L, Argañaraz, Enrique R, Oshiro, Telma M, Pontillo, Alessandra
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2019
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't HIV-1, chronic infection IL-18 IL-1ß Inflammasome NLRP3 IL18 protein, human Inflammasomes Interleukin-18 mehr... Interleukin-1beta NLR Family, Pyrin Domain-Containing 3 Protein NLRP3 protein, human
LEADER 01000naa a22002652 4500
001 NLM302736816
003 DE-627
005 20231225111344.0
007 cr uuu---uuuuu
008 231225s2019 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2019.108266  |2 doi 
028 5 2 |a pubmed24n1009.xml 
035 |a (DE-627)NLM302736816 
035 |a (NLM)31669192 
035 |a (PII)S1521-6616(19)30476-0 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Reis, Edione C  |e verfasserin  |4 aut 
245 1 0 |a Antagonistic role of IL-1ß and NLRP3/IL-18 genetics in chronic HIV-1 infection 
264 1 |c 2019 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 20.05.2020 
500 |a Date Revised 19.10.2020 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2019 Elsevier Inc. All rights reserved. 
520 |a Host genetics affects both susceptibility and progression of HIV-1 infection. NLRP3 inflammasome provides a first-line defense in viral infections, and, accordingly, gain-of-function variants in NLRP3 have been associated with protection against HIV-1. Despite antiretroviral treatment (ART), HIV-infected patients continue to present systemic inflammation with a heterogeneous prognosis. As NLRP3 inflammasome is involved in several chronic diseases by amplifying "sterile" inflammation, its role in chronic phase of HIV infection has been postulated. Little is known about inflammasome genetics in HIV-infected patients and whether it may play a role in the different clinical outcomes. Therefore, we questioned whether NLRP3 inflammasome genetics could affect the clinical course of HIV-1 infection as it does in host/virus interaction. For this purpose, we analyzed selected single nucleotide polymorphisms (SNPs) in ART-treated HIV-infected patients (n = 300), in Long Term Non-Progressors/Elite Controllers and progressors (n = 133), and in HIV-infected individuals submitted to dendritic cell (DC)-based immunotherapy (n = 19). SNPs leading to increased activation of NLRP3 inflammasome are beneficial for patients, while SNPs that negatively affect NLRP3 activation or IL-18 production, detrimental. In contrast, gain-of-function variant in IL1B is also detrimental for patients, suggesting that while IL-1ß possible contributes to immune exhaustion, the axis NLRP3-inflammasome/IL-18 could act positively in chronic infection. Functional assays supported genetic results: NLRP3 variants associated with good quality HIV+ DC, and IL1B -511C > T with a poor one. Loss-of-function SNPs affect HIV+ T cells proliferation. These findings proposed for the first time that NLRP3 inflammasome, mainly through IL-18, play a protective role in chronic HIV infection 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a HIV-1, chronic infection 
650 4 |a IL-18 
650 4 |a IL-1ß 
650 4 |a Inflammasome 
650 4 |a NLRP3 
650 7 |a IL18 protein, human  |2 NLM 
650 7 |a Inflammasomes  |2 NLM 
650 7 |a Interleukin-18  |2 NLM 
650 7 |a Interleukin-1beta  |2 NLM 
650 7 |a NLR Family, Pyrin Domain-Containing 3 Protein  |2 NLM 
650 7 |a NLRP3 protein, human  |2 NLM 
700 1 |a Leal, Vinicius N C  |e verfasserin  |4 aut 
700 1 |a da Silva, Lais T  |e verfasserin  |4 aut 
700 1 |a Dos Reis, Marilia M L  |e verfasserin  |4 aut 
700 1 |a Argañaraz, Enrique R  |e verfasserin  |4 aut 
700 1 |a Oshiro, Telma M  |e verfasserin  |4 aut 
700 1 |a Pontillo, Alessandra  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 209(2019) vom: 16. Dez., Seite 108266  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:209  |g year:2019  |g day:16  |g month:12  |g pages:108266 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2019.108266  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 209  |j 2019  |b 16  |c 12  |h 108266